Please use this identifier to cite or link to this item: https://doi.org/10.1517/14656566.6.11.1883
DC FieldValue
dc.titleFluvastatin: Efficacy and safety in reducing cardiac events
dc.contributor.authorChan, M.Y.
dc.contributor.authorLee, C.H.
dc.date.accessioned2016-12-13T05:39:49Z
dc.date.available2016-12-13T05:39:49Z
dc.date.issued2005-09
dc.identifier.citationChan, M.Y., Lee, C.H. (2005-09). Fluvastatin: Efficacy and safety in reducing cardiac events. Expert Opinion on Pharmacotherapy 6 (11) : 1883-1895. ScholarBank@NUS Repository. https://doi.org/10.1517/14656566.6.11.1883
dc.identifier.issn14656566
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/133067
dc.description.abstractThe importance of statin therapy in lipid-lowering and its role in primary and secondary prevention has been borne out of numerous clinical trials conducted over the last two decades. Concurrently, much concern has been expressed over the safety and tolerability of these drugs. Fluvastatin has demonstrated good clinical efficacy and safety. This paper reviews the various pharmacological properties and evidence supporting its use in the prevention of cardiac events. © 2005 Ashley Publications Ltd.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1517/14656566.6.11.1883
dc.sourceScopus
dc.subjectClinical trials
dc.subjectFluvastatin
dc.subjectPharmacodynamics
dc.subjectPharmacokinetics
dc.subjectSafety
dc.typeReview
dc.contributor.departmentMEDICINE
dc.description.doi10.1517/14656566.6.11.1883
dc.description.sourcetitleExpert Opinion on Pharmacotherapy
dc.description.volume6
dc.description.issue11
dc.description.page1883-1895
dc.description.codenEOPHF
dc.identifier.isiut000232263000008
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.